Release Date: 17/01/13 19:57 Summary: Quarterly Activities Report - December 2012 Price Sensitive: Yes Download Document 1.84MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%